Efficacy and safety of add-on parsaclisib to ruxolitinib therapy in myelofibrosis patients with low versus higher baseline platelet counts: A subgroup analysis of data from a phase 2 study Meeting Abstract
| Authors: | Yacoub, A.; Borate, U.; Rampal, R.; Ali, H.; Wang, E.; Gerds, A.; Hobbs, G.; Kremyanskaya, M.; Winton, E.; O'Connell, C.; Goel, S.; Oh, S.; Schiller, G.; Assad, A.; Erickson-Viitanen, S.; Zhou, F.; Daver, N. |
| Abstract Title: | Efficacy and safety of add-on parsaclisib to ruxolitinib therapy in myelofibrosis patients with low versus higher baseline platelet counts: A subgroup analysis of data from a phase 2 study |
| Meeting Title: | 10th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | myelofibrosis; phase ii; pi3k; platelet count; ruxolitinib; mpn |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 22 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Sep 28-Oct 1 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-10-01 |
| Start Page: | S324 |
| Language: | English |
| ACCESSION: | WOS:000897948100312 |
| PROVIDER: | wos |
| DOI: | 10.1016/s2152-2650(22)01433-1 |
| Notes: | Meeting Abstract: MPN-075 -- Source: Wos |
